Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Stefano Boccasile"'
Autor:
Luca Cindolo, Clara Natoli, Cosimo De Nunzio, Michele De Tursi, Maurizio Valeriani, Silvana Giacinti, Salvatore Micali, Mino Rizzo, Giampaolo Bianchi, Eugenio Martorana, Marcello Scarcia, Giuseppe Mario Ludovico, Pierluigi Bove, Anastasia Laudisi, Oscar Selvaggio, Giuseppe Carrieri, Maida Bada, Pietro Castellan, Stefano Boccasile, Pasquale Ditonno, Paolo Chiodini, Paolo Verze, Vincenzo Mirone, Luigi Schips
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-8 (2017)
Abstract Background To evaluate the safety and efficacy of abiraterone acetate (AA) in the “real life” clinical practice for men with chemotherapy-naïve metastatic castration-resistant prostate. Methods A consecutive series of patients with mCRP
Externí odkaz:
https://doaj.org/article/981184a786e2492083d7bce0054f6fa3
Autor:
Maida Bada, Felice Crocetto, Peter Nyirady, Vincenzo Pagliarulo, Sebastiano Rapisarda, Antonio Aliberti, Stefano Boccasile, Matteo Ferro, Biagio Barone, Antonio Celia
Objectives To compare differences of operative outcomes, post-operative complications and survival outcomes between open and laparoscopic cases in a multicenter study. Methods This was a retrospective cohort study performed at three European centers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae53a7e0ee9fa378762357966c64bb1f
https://hdl.handle.net/11588/918157
https://hdl.handle.net/11588/918157
Autor:
Riccardo Autorino, Judith Varga, Georgi Guruli, Luigi Schips, Alessandro Veccia, Stefano Puliatti, Salvatore Micali, Luca Cindolo, Stefano Boccasile, Pasquale Ditonno, Andrea Tubaro, Alessandro Antonelli, Jamil Ghahhari, Roman Sosnowski, Andrew Tracey, A. Conti, Mario Alvarez-Maestro, Juan Chipollini, Giorgia Tema, José Quesada Olarte, Petros Sountoulides, Gennaro Musi, Marcos Venicio Alves Lima, Erico Diogenes, Michele Marchioni, Cosimo De Nunzio, Philippe E. Spiess, Péter Nyirády, Ottavio De Cobelli, Giulia Primiceri
Publikováno v:
Transl Androl Urol
Background The use of organ sparing strategies to treat penile cancer (PC) is currently supported by evidence that has indicated the safety, efficacy and benefit of this surgery. However, radical penectomy still represents up to 15-20% of primary tum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22e5cb316719e35a3864d4089e60083b
http://hdl.handle.net/11573/1460315
http://hdl.handle.net/11573/1460315
Autor:
Maida Bada, Eugenio Martorana, Luigi Schips, Silvana Giacinti, Cosimo De Nunzio, Giuseppe Mario Ludovico, Marcello Scarcia, Stefano Boccasile, Giampaolo Bianchi, Maurizio Valeriani, Anastasia Laudisi, Salvatore Micali, Pasquale Ditonno, Mino Rizzo, Clara Natoli, Paolo Verze, Oscar Selvaggio, Michele De Tursi, Luca Cindolo, Vincenzo Mirone, Paolo Chiodini, Pierluigi Bove, Giuseppe Carrieri, Pietro Castellan
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-8 (2017)
BMC Cancer
BMC Cancer
Background To evaluate the safety and efficacy of abiraterone acetate (AA) in the “real life” clinical practice for men with chemotherapy-naïve metastatic castration-resistant prostate. Methods A consecutive series of patients with mCRPC in 9 It
Autor:
Salvatore Micali, Paolo Chiodini, Stefano Boccasile, Cosimo De Nunzio, Pasquale Ditonno, Maida Bada, Péter Nyirády, Alessandro Antonelli, Francesco Berardinelli, Luigi Schips, Claudio Simeone, Stefano Puliatti, Luca Cindolo, Michele Battaglia, James Varga, Giorgia Tema, Andrea Veccia
Publikováno v:
Journal of Urology. 197
Autor:
Maida Bada, Stefano Boccasile, Michele De Tursi, Mino Rizzo, Salvatore Micali, Pasquale Ditonno, Marcello Scarcia, Cosimo De Nunzio, Paolo Chiodini, Anastasia Laudisi, Luigi Schips, Giampaolo Bianchi, Oscar Selvaggio, Luca Topazio, Eugenio Martorana, Silvana Giacinti, Pierluigi Bove, Luca Cindolo, Clara Natoli, Giuseppe Carrieri, Giuseppe Mario Ludovico, Maurizio Valeriani, Pietro Castellan
Publikováno v:
Clinical genitourinary cancer. 15(5)
This article highlights the possible role of “patient-reported outcomes” in the evaluation of a new therapy. Abiraterone acetate is a novel treatment for metastatic prostate cancer characterized by good safety and oncologic efficacy. Few studies